Benzinga | Apr 12, 2021 12:04PM EDT

Zacks Investment Research Initiates Coverage On Tiziana Life Sciences with Not Rated Rating, Announces Price Target of $7.5

Zacks Investment Research analyst John Vandermosten initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Not Rated rating and announces Price Target of $7.5.